Grade and prognosis

What it is

Tumor grade — a measure of how aggressive a glioma appears and behaves (on a scale of 1 to 4) — is a major determinant of prognosis. Lower-grade tumors generally have a better outlook, while higher-grade tumors are more aggressive. In modern classification, grade is considered together with molecular features.

Understanding Grade and prognosis

Grade reflects how aggressive a tumor is: grade 1 tumors are the least aggressive (some are curable, like pilocytic astrocytoma), while grade 4 tumors are the most aggressive (such as glioblastoma). As a general rule, the lower the grade, the better the outlook, making grade one of the most important prognostic factors. However, in the modern understanding, grade does not act alone — molecular features are integral. For example, an IDH-mutant grade 4 astrocytoma generally has a better outlook than IDH-wildtype glioblastoma despite both being grade 4, because the IDH mutation is favorable; and grade itself is now sometimes determined partly by molecular markers (such as CDKN2A/B deletion). So grade and molecular features together shape prognosis. Grade is also considered with other factors (age, performance status, extent of resection). It influences probabilities at the population level. Understanding grade and prognosis in gliomas clarifies how aggressiveness relates to outlook, in concert with molecular features.

Why it matters

Understanding grade and prognosis helps patients and families see how a tumor's grade relates to its outlook — lower grades generally more favorable — while recognizing that molecular features are now integral to this picture.